Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Pre-Filled Syringes: End-to-End Processing Training Course" has been added to ResearchAndMarkets.com's offering. This intensive two-day course has been ...
The 0.3mg PFS marks the first approved syringe with an anti-vascular endothelial growth factor (VEGF) to treat all forms of diabetic retinopathy with or without diabetic macular edema (DME). Genentech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback